(Q37581938)

21 August 2017

1 reference

title

Exercise and muscle dysfunction in COPD: implications for pulmonary rehabilitation (English)

1 reference

chronic obstructive pulmonary disease

21 August 2017

1 reference

3

John Moxham

1 reference

21 August 2017

4

Michael I Polkey

1 reference

21 August 2017

William D-C Man

1

1 reference

PubMed ID

19689433

21 August 2017

Paul Kemp

series ordinal

2

1 reference

PubMed ID

19689433

21 August 2017

language of work or name

English

0 references

publication date

24 August 2009

1 reference

21 August 2017

1 reference

21 August 2017

117

1 reference

21 August 2017

8

1 reference

21 August 2017

281-291

1 reference

Skeletal muscle dysfunction in COPD: clinical and laboratory observations

21 August 2017

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Pulmonary rehabilitation in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Short- and long-term effects of outpatient rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Resistance versus endurance training in patients with COPD and peripheral muscle weakness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Loss of skeletal muscle mass in aging: examining the relationship of starvation, sarcopenia and cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Skeletal muscle hypertrophy and atrophy signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Stimulation of slow skeletal muscle fiber gene expression by calcineurin in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Calcineurin is not involved in some mitochondrial enzyme adaptations to endurance exercise training in rat skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Role of calcineurin in exercise-induced mitochondrial biogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Skeletal muscle reprogramming by activation of calcineurin improves insulin action on metabolic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Calcineurin does not mediate exercise-induced increase in muscle GLUT4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Skeletal muscle adaptation in response to voluntary running in Ca2+/calmodulin-dependent protein kinase IV-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Regulation of GLUT4 biogenesis in muscle: evidence for involvement of AMPK and Ca(2+).

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Adaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivator PGC-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Muscle-specific expression of PPARgamma coactivator-1alpha improves exercise performance and increases peak oxygen uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Endurance training in humans leads to fiber type-specific increases in levels of peroxisome proliferator-activated receptor-gamma coactivator-1 and peroxisome proliferator-activated receptor-alpha in skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Peroxisome proliferator-activated receptor expression is reduced in skeletal muscle in COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Effects of chronic AICAR treatment on fiber composition, enzyme activity, UCP3, and PGC-1 in rat muscles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Skeletal muscle adaptation to exercise training: AMP-activated protein kinase mediates muscle fiber type shift

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

AMPK activation increases fatty acid oxidation in skeletal muscle by activating PPARalpha and PGC-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

AMPK and PPARdelta agonists are exercise mimetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

AMP-activated protein kinase agonists increase mRNA content of the muscle-specific ubiquitin ligases MAFbx and MuRF1 in C2C12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Aerobic and strength training in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

General exercise training improves ventilatory and peripheral muscle strength and endurance in chronic airflow limitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Comparison of effects of strength and endurance training in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Effect of pulmonary rehabilitation on quadriceps fatiguability during exercise.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Effects of testosterone and resistance training in men with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

A role for anabolic steroids in the rehabilitation of patients with COPD? A double-blind, placebo-controlled, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

From muscle disuse to myopathy in COPD: potential contribution of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Skeletal muscles in chronic obstructive pulmonary disease: deconditioning, or myopathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Long-term effects of outpatient rehabilitation of COPD: A randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

How long should outpatient pulmonary rehabilitation be? A randomised controlled trial of 4 weeks versus 7 weeks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Contractile leg fatigue after cycle exercise: a factor limiting exercise in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Effects of hyperoxia on ventilatory limitation during exercise in advanced chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Factors contributing to relief of exertional breathlessness during hyperoxia in chronic airflow limitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Supplemental oxygen during pulmonary rehabilitation in patients with COPD with exercise hypoxaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Effect of heliox on lung dynamic hyperinflation, dyspnea, and exercise endurance capacity in COPD patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

The effect of helium and oxygen on exercise performance in chronic obstructive pulmonary disease: a randomized crossover trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Effects of training with heliox and noninvasive positive pressure ventilation on exercise ability in patients with severe COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Non-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Effect of inspiratory pressure support on exercise tolerance and breathlessness in patients with severe stable chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Proportional assist ventilation as an aid to exercise training in severe chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Noninvasive ventilation during exercise training improves exercise tolerance in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Lack of additional effect of adjunct of assisted ventilation to pulmonary rehabilitation in mild COPD patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Community pulmonary rehabilitation after hospitalisation for acute exacerbations of chronic obstructive pulmonary disease: randomised controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Non-volitional assessment of skeletal muscle strength in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Inspiratory muscle training in patients with chronic obstructive pulmonary disease: structural adaptation and physiologic outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Effects of controlled inspiratory muscle training in patients with COPD: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Injury of the human diaphragm associated with exertion and chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Home based neuromuscular electrical stimulation as a new rehabilitative strategy for severely disabled patients with chronic obstructive pulmonary disease (COPD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Randomised controlled trial of transcutaneous electrical muscle stimulation of the lower extremities in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Peripheral muscle strength training in bed-bound patients with COPD receiving mechanical ventilation: effect of electrical stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Nutritional enhancement of exercise performance in chronic obstructive pulmonary disease: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

The effects of refeeding on peripheral and respiratory muscle function in malnourished chronic obstructive pulmonary disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Efficacy of nutritional supplementation therapy in depleted patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Reversal of COPD-associated weight loss using the anabolic agent oxandrolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Hypogonadism in men with chronic obstructive pulmonary disease: prevalence and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Hypogonadism, quadriceps weakness, and exercise intolerance in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Skeletal muscle adaptations to testosterone and resistance training in men with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Musculoskeletal effects of the recombinant human IGF-I/IGF binding protein-3 complex in osteoporotic patients with proximal femoral fracture: a double-blind, placebo-controlled pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Effect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): a randomised placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Does oxidative stress alter quadriceps endurance in chronic obstructive pulmonary disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Therapeutic prospects to treat skeletal muscle wasting in COPD (chronic obstructive lung disease).

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Identification of ubiquitin ligases required for skeletal muscle atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Muscle atrophy and hypertrophy signaling in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Functional improvement of dystrophic muscle by myostatin blockade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

The role of exercise and PGC1alpha in inflammation and chronic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Gene expression-based screening identifies microtubule inhibitors as inducers of PGC-1alpha and oxidative phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

Body Mass, Fat-Free Body Mass, and Prognosis in Patients with Chronic Obstructive Pulmonary Disease from a Random Population Sample: Findings from the Copenhagen City Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20080660

21 January 2018

Identifiers

DOI

10.1042/CS20080660

1 reference

21 August 2017

1 reference

PubMed ID

19689433